Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma. (2020)
Attributed to:
Manipulation of the Complement Pathway to Increase Radiation Sensitivity and Immune Response
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/1753425919876690
PubMed Identifier: 31547758
Publication URI: http://europepmc.org/abstract/MED/31547758
Type: Journal Article/Review
Volume: 26
Parent Publication: Innate immunity
Issue: 2
ISSN: 1753-4259